AACR Annual Meeting 2023 AACR 2023: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable NSCLC
Gynecologic Cancers COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium